标题
Parkinson’s Disease and the COVID-19 Pandemic
作者
关键词
-
出版物
Journal of Parkinsons Disease
Volume -, Issue -, Pages 1-14
出版商
IOS Press
发表日期
2021-01-20
DOI
10.3233/jpd-202320
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients
- (2020) Yan‐Chao Li et al. JOURNAL OF MEDICAL VIROLOGY
- Steroid‐responsive encephalitis in Covid‐19 disease
- (2020) Andrea Pilotto et al. ANNALS OF NEUROLOGY
- Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment
- (2020) Sandra P. Smieszek et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19
- (2020) Serge Nataf JOURNAL OF MEDICAL VIROLOGY
- Onset of Covid-19 with impaired consciousness and ataxia: a case report
- (2020) R. Balestrino et al. JOURNAL OF NEUROLOGY
- Movement Disorder Society–Unified Parkinson's Disease Rating Scale Use in the Covid‐19 Era
- (2020) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Mental health, physical activity and quality of life in Parkinson's disease during COVID‐19 pandemic
- (2020) Ali Shalash et al. MOVEMENT DISORDERS
- Impact of the COVID ‐19 Pandemic on Parkinson's Disease and Movement Disorders
- (2020) Stella M. Papa et al. MOVEMENT DISORDERS
- SARS‐CoV ‐2: At the Crossroad Between Aging and Neurodegeneration
- (2020) Alice Lippi et al. MOVEMENT DISORDERS
- A Post‐COVID ‐19 Parkinsonism in the Future?
- (2020) Aliaksandr V. Boika MOVEMENT DISORDERS
- Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease ( COVID ‐19) Pandemic
- (2020) Mehri Salari et al. MOVEMENT DISORDERS
- Effects of COVID‐19 on Parkinson's disease clinical features: a community‐based case‐control study
- (2020) Roberto Cilia et al. MOVEMENT DISORDERS
- Outcome of Parkinson's Disease Patients Affected by COVID ‐19
- (2020) Angelo Antonini et al. MOVEMENT DISORDERS
- Parkinson's Disease and COVID ‐19: Perceptions and Implications in Patients and Caregivers
- (2020) Shweta Prasad et al. MOVEMENT DISORDERS
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
- (2020) Tommaso Schirinzi et al. NEUROLOGICAL SCIENCES
- Generalized myoclonus in COVID-19
- (2020) Pablo Rábano-Suárez et al. NEUROLOGY
- Rapid worsening in Parkinson's disease may hide COVID-19 infection
- (2020) Elodie Hainque et al. PARKINSONISM & RELATED DISORDERS
- Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis
- (2020) Jaber S. Alqahtani et al. PLoS One
- The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities
- (2020) Rick C. Helmich et al. Journal of Parkinsons Disease
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
- (2020) Ling Mao et al. JAMA Neurology
- Vitamin-D and COVID-19: do deficient risk a poorer outcome?
- (2020) Fiona Mitchell Lancet Diabetes & Endocrinology
- Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson’s Disease in Germany
- (2020) Hannah M. Zipprich et al. Journal of Clinical Medicine
- Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson’s Disease
- (2020) Casey A. Hribar et al. Brain Sciences
- SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis
- (2020) Chitra Mohinder Singh Singal et al. ACS Chemical Neuroscience
- Amantadine Treatment for People with COVID-19
- (2020) Ramiro Araújo et al. ARCHIVES OF MEDICAL RESEARCH
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
- (2020) Ross W Paterson et al. BRAIN
- Neuropathologic features of four autopsied COVID‐19 patients
- (2020) Jonas Kantonen et al. BRAIN PATHOLOGY
- A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
- (2020) Liuliu Yang et al. Cell Stem Cell
- A First Case of Acute Cerebellitis Associated with Coronavirus Disease (COVID-19): a Case Report and Literature Review
- (2020) Nima Fadakar et al. CEREBELLUM
- Patterns of smell recovery in 751 patients affected by the COVID‐19 outbreak
- (2020) C. M. Chiesa‐Estomba et al. EUROPEAN JOURNAL OF NEUROLOGY
- Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement
- (2020) Scott R. Beach et al. GENERAL HOSPITAL PSYCHIATRY
- Use of amantadine in a patient with SARS‐CoV‐2
- (2020) Gonzalo Emiliano Aranda‐Abreu et al. JOURNAL OF MEDICAL VIROLOGY
- Postinfectious brainstem encephalitis associated with SARS-CoV-2
- (2020) Anthony Khoo et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18F-FDG PET imaging and neuronal autoantibodies
- (2020) Stephan Grimaldi et al. JOURNAL OF NUCLEAR MEDICINE
- Neurological associations of COVID-19
- (2020) Mark A Ellul et al. LANCET NEUROLOGY
- Amantadine as a drug to mitigate the effects of COVID-19
- (2020) Gonzalo Emiliano Aranda Abreu et al. MEDICAL HYPOTHESES
- Phenomenology and Outcomes of In‐Patients With Parkinson's Disease During the Coronavirus Disease 2019 Pandemic
- (2020) Christopher Kobylecki et al. MOVEMENT DISORDERS
- Impact of COVID ‐19 pandemic on cognition in Parkinson's disease
- (2020) Giovanni Palermo et al. MOVEMENT DISORDERS
- The Possible Protective Role of α‐Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease
- (2020) Sofiane Ait Wahmane et al. MOVEMENT DISORDERS
- COVID ‐19 in Parkinson’s Disease Patients Living in Lombardy, Italy
- (2020) Alfonso Fasano et al. MOVEMENT DISORDERS
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- New insights into the neurological effects of COVID-19
- (2020) Heather Wood Nature Reviews Neurology
- Temblor y ataxia en COVID-19
- (2020) A.M. Diezma-Martín et al. NEUROLOGIA
- Does amantadine have a protective effect against COVID-19?
- (2020) Albert Cortés Borra Neurologia i Neurochirurgia Polska
- Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection
- (2020) Antonio Méndez-Guerrero et al. NEUROLOGY
- New onset neurologic events in people with COVID-19 infection in three regions in China
- (2020) Weixi Xiong et al. NEUROLOGY
- Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review
- (2020) João Vitor Vieira de Siqueira et al. Obesity Research & Clinical Practice
- Predictors of COVID-19 outcome in Parkinson's disease
- (2020) Alfonso Fasano et al. PARKINSONISM & RELATED DISORDERS
- Acute meningoencephalitis in a patient with COVID-19
- (2020) H. Chaumont et al. REVUE NEUROLOGIQUE
- Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment
- (2020) Konrad Rejdak et al. Multiple Sclerosis and Related Disorders
- Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients
- (2020) David García-Azorín et al. Frontiers in Neurology
- Targeting COVID-19 in Parkinson’s patients: Drugs repurposed.
- (2020) Firoz Anwar et al. CURRENT MEDICINAL CHEMISTRY
- Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study
- (2020) Andrea Pilotto et al. JOURNAL OF INFECTIOUS DISEASES
- COVID-19 in Parkinson’s disease: what holds the key?
- (2020) R. Sainz-Amo et al. JOURNAL OF NEUROLOGY
- Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region
- (2020) Eleonora Del Prete et al. JOURNAL OF NEUROLOGY
- Management of Parkinson's disease patients after DBS by remote programming: preliminary application of single center during quarantine of 2019-nCoV
- (2020) Jinyu Xu et al. JOURNAL OF NEUROLOGY
- COVID-19 impact on consecutive neurological patients admitted to the emergency department
- (2020) Andrea Pilotto et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A case of probable Parkinson's disease after SARS-CoV-2 infection
- (2020) Mikhal E Cohen et al. LANCET NEUROLOGY
- Telemedicine in Movement Disorders: Leçons du Coronavirus Disease 2019
- (2020) Eoin Mulroy et al. MOVEMENT DISORDERS
- Coronavirus Disease 2019 and Parkinsonism: A Non‐post‐encephalitic Case
- (2020) Ingrid Faber et al. MOVEMENT DISORDERS
- A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City
- (2020) Jennifer A. Frontera et al. NEUROLOGY
- Is COVID-19 a Perfect Storm for Parkinson’s Disease?
- (2020) Patrik Brundin et al. TRENDS IN NEUROSCIENCES
- Parkinson's Disease Remote Patient Monitoring During the COVID-19 Lockdown
- (2020) Francesco Motolese et al. Frontiers in Neurology
- COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
- (2020) David Sulzer et al. npj Parkinsons Disease
- A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies
- (2019) Alberto J. Espay et al. MOVEMENT DISORDERS
- Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial
- (2019) Nicolien M van der Kolk et al. LANCET NEUROLOGY
- Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra
- (2019) Ana I. Rodriguez-Perez et al. BRAIN BEHAVIOR AND IMMUNITY
- Influence of Parkinsonism on outcomes of elderly pneumonia patients
- (2018) Taisuke Jo et al. PARKINSONISM & RELATED DISORDERS
- Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection
- (2017) Viviane Labrie et al. Journal of Innate Immunity
- The promise of telemedicine for chronic neurological disorders: the example of Parkinson's disease
- (2017) Ruth B Schneider et al. LANCET NEUROLOGY
- Treadmill exercise modifies dopamine receptor expression in the prefrontal cortex of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of Parkinson’s disease
- (2017) Natalie Kintz et al. NEUROREPORT
- Alpha-Synuclein, a Novel Viral Restriction Factor Hiding in Plain Sight
- (2016) Aaron R. Massey et al. DNA AND CELL BIOLOGY
- Frontline Science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI
- (2016) Nathaniel B. Bone et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2016) Lauren Hirsch et al. NEUROEPIDEMIOLOGY
- Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease
- (2016) Xiao-Yan Qin et al. JAMA Neurology
- Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain
- (2015) Erica L. Beatman et al. JOURNAL OF VIROLOGY
- A feasibility study of conducting the Montreal Cognitive Assessment remotely in individuals with movement disorders
- (2014) Amir Abdolahi et al. Health Informatics Journal
- Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease
- (2014) Wenbin Xiao et al. IMMUNOBIOLOGY
- Delirium and High Fever Are Associated with Subacute Motor Deterioration in Parkinson Disease: A Nested Case-Control Study
- (2014) Atsushi Umemura et al. PLoS One
- Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease
- (2013) Giselle M Petzinger et al. LANCET NEUROLOGY
- Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study
- (2013) H. Ding et al. NEUROLOGY
- Clinical Characteristics of Exacerbations in Parkinson Disease
- (2012) Karen S. Zheng et al. NEUROLOGIST
- Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis
- (2010) J. J. Gagne et al. NEUROLOGY
- The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease
- (2009) Belen Joglar et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started